Phase II Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Oesophageal Squamous Carcinoma After Failure of Conventional Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2016
At a glance
- Drugs Icotinib (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 21 Apr 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2017.
- 21 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Sep 2017.
- 18 Feb 2014 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.